Saturday 17 October 2026
Export PHG’s income statement to Excel — free account
Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.
25.74
0.25
+0.98%
Follow PHG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | — | — | — |
+8 more TTM periods Free account |
| 10.20% | 8.63% | 8.02% | 5.98% | ||
| 4.21% | 3.67% | 3.25% | 2.44% | ||
ROIC |
6.69% | 5.91% | 5.91% | 4.64% | |
Return on Tangible Assets |
27.07% | 20.90% | 19.29% | 14.68% | |
Average Days of Receivables |
74.19 | 69.14 | 73.47 | 74.25 | |
Free Cash Flow per Share |
1.94 | 1.85 | 0.61 | (1.30) | |
Free Cash Flow |
1,849.65 | 1,763.60 | 580.41 | (1,234.96) | |
Capital Expenditures |
(751.93) | (765.35) | (745.59) | (890.67) | |
| Other line items | |||||
Cash ROIC |
8.10% | 7.18% | 2.47% | (5.33%) | |
Accounts Receivable Turnover |
5.17 | 5.42 | 4.86 | 4.71 | |
Accounts Payable Turnover |
3.70 | 5.26 | 5.30 | 5.48 | |
Inventory Turnover |
3.00 | 3.13 | 3.10 | 2.52 | |
Average Days of Payables |
79.35 | 75.92 | 71.95 | 70.19 | |
Days of Inventory on Hand |
122.68 | 118.66 | 107.16 | 133.57 | |
Tax Rate |
(0.25) | (0.24) | (0.24) | (0.29) | |
Research and Development Expense of Revenue |
9.77% | 9.31% | 9.53% | 9.95% | |
Selling, General and Administrative Expense of Revenue |
27.66% | 27.87% | 27.87% | 28.54% | |
Share Based Compensation of Revenue |
0.80% | 0.71% | 0.79% | 0.89% | |
Interest Coverage |
4.70 | 4.30 | 4.12 | 3.59 | |
Operating CF/Net income |
2.03 | 2.28 | 1.31 | (0.45) | |
Depreciation/Fixed assets |
0.56 | 0.51 | 0.51 | 0.65 | |
Capex/Depreciation |
(0.53) | (0.59) | (0.59) | (0.53) | |
Revenue per Share |
21.53 | 21.47 | 21.28 | 20.07 | |
Operating CF per Share |
2.72 | 2.66 | 1.40 | (0.36) | |
Capex per Share |
(0.79) | (0.80) | (0.79) | (0.94) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.05 |
Columns are period end dates